Vagus Nerve Stimulation Therapy News Vagus Nerve Stimulation Therapy RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

At-Home Vagus Nerve Stimulation Promising for Postpartum Depression At-Home Vagus Nerve Stimulation Promising for Postpartum Depression
Noninvasive, high frequency auricular vagus nerve stimulation therapy was well tolerated and associated with a reduction in depressive and anxiety symptoms in postpartum depression.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 1, 2022 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Vagus Nerve Stimulation: A Little-Known Option for Depression Vagus Nerve Stimulation: A Little-Known Option for Depression
The treatment, which is less well known than electroconvulsive therapy, appears to provide additional benefit when administered with standard antidepressant therapy.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - May 5, 2022 Category: Psychiatry Tags: Psychiatry News Source Type: news

Understanding mental health needs and gathering feedback on transcutaneous auricular vagus nerve stimulation as a potential PTSD treatment among 9/11 responders living with PTSD symptoms 20 years later: a qualitative approach - Schwartz RM, Shaam P, Williams MS, McCann-Pineo M, Ryniker L, Debnath S, Zanos TP.
Posttraumatic stress disorder (PTSD) remains one of the most prevalent diagnoses of World Trade Center (WTC) 9/11 responders. Transcutaneous auricular vagus nerve stimulation (taVNS) is a potential treatment for PTSD, as it can downregulate activity in the... (Source: SafetyLit)
Source: SafetyLit - April 25, 2022 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

VNS May Cut Hospital Costs for Children With Refractory Epilepsy
FRIDAY, April 1, 2022 -- Antiseizure medication (ASM) plus vagus nerve stimulation (VNS) is associated with lower annual hospital costs over time for pediatric patients with refractory epilepsy compared to ASM alone, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2022 Category: Pharmaceuticals Source Type: news

MicroTransponder(R) Receives FDA Approval for Breakthrough Device Benefiting Stroke Survivors
The first-of-its-kind Vivistim® Paired Vagus Nerve Stimulation (VNS) System significantly improves upper limb rehabilitation therapy DALLAS, Aug. 31, 2021 -- (Healthcare Sales & Marketing Network) -- MicroTransponder, Inc. today announced United St... Devices, Neurology, FDA MicroTransponder, Vivistim Paired VNS System, Vagus Nerve Stimulation, stroke (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 31, 2021 Category: Pharmaceuticals Source Type: news

FDA OKs First Vagus Nerve Stimulation System for Stroke Rehab FDA OKs First Vagus Nerve Stimulation System for Stroke Rehab
The US Food and Drug Administration has approved a first-of-its kind vagus nerve stimulation system to treat moderate-to-severe upper extremity motor deficits associated with chronic ischemic stroke.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - August 27, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news

Rehab + Vagus Nerve Stimulation May Restore Arm Function After Stroke
MONDAY, May 10, 2021 -- Patients with long-term loss of arm function after ischemic stroke have improvement in arm function following rehabilitation paired with vagus nerve stimulation (VNS), according to a study published in the April 24 issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 10, 2021 Category: Pharmaceuticals Source Type: news

Vagus Nerve Stimulation, Rehab Effective After Stroke Vagus Nerve Stimulation, Rehab Effective After Stroke
Vagus nerve stimulation combined with rehabilitation exceeds rehabilitation alone for poststroke arm weakness, new research suggests.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - April 29, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Surgical procedure may help restore hand and arm function after stroke
(University of Southern California - Health Sciences) Patients who received a novel treatment that combines vagus nerve stimulation (VNS) and rehabilitation showed improvement in upper body motor impairment compared to those who received sham (inactive form of) stimulation and rehabilitation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 26, 2021 Category: International Medicine & Public Health Source Type: news

Noninvasive Vagus Nerve Stimulation Tolerated, Effective for Rheumatoid Arthritis Noninvasive Vagus Nerve Stimulation Tolerated, Effective for Rheumatoid Arthritis
Noninvasive vagus nerve stimulation is safe and effective as an intervention for rheumatoid arthritis, a small proof-of-concept study suggests.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - March 22, 2021 Category: Orthopaedics Tags: Rheumatology News Source Type: news

Video: Vagus nerve stimulation
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - November 17, 2020 Category: Consumer Health News Source Type: news

VNS May Improve Upper-Limb Rehabilitation After Stroke VNS May Improve Upper-Limb Rehabilitation After Stroke
About half of patients who underwent vagus nerve stimulation and intensive rehabilitation had improved functional response vs sham stimulation with rehab, with low adverse event rates.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 16, 2020 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news

Study Could Add More Depth to Bioelectronic Medicine
This study is one of several that we’re conducting and there are more coming out in the next few months,” he said. “I see this study and [the upcoming studies] as part of this big story that has to do with building the second generation vagus nerve stimulation therapies – that will be much more effective and much safer. It will allow a lot of flexibility to healthcare providers in individualizing the therapy to specific subjects.” (Source: MDDI)
Source: MDDI - June 9, 2020 Category: Medical Devices Authors: Omar Ford Tags: Digital Health R & Source Type: news

The effects of vagus nerve stimulation on the course and outcomes of patients with bipolar disorder in a treatment-resistant depressive episode: a 5-year prospective registry - McAllister-Williams RH, Sousa S, Kumar A, Greco T, Bunker MT, Aaronson ST, Conway CR, Rush AJ.
BACKGROUND: To compare illness characteristics, treatment history, response and durability, and suicidality scores over a 5-year period in patients with treatment-resistant bipolar depression participating in a prospective, multicenter, open-label registry... (Source: SafetyLit)
Source: SafetyLit - May 6, 2020 Category: International Medicine & Public Health Tags: Program and Other Evaluations, Effectiveness Studies Source Type: news

Medtronic Rumored to Be Looking at a Deal with LivaNova
Reorg Research reported that Medtronic is in early-stage acquisition talks with LivaNova, news that has been well received by LivaNova shareholders. The firm said Medtronic would subsequently break up LivaNova, keeping its neuromodulation business and selling its cardiovascular business. The article does note, however, that Boston Scientific, Edwards Life Sciences, and Johnson & Johnson may also be interested in the London-based company. Mike Matson, an analyst at Needham & Co., performed a sum-of-parts analysis that values LivaNova's cardiovascular and neuromodulation businesses separately. His analysi...
Source: MDDI - February 28, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Cardiovascular Source Type: news